Photo by James Yarema on Unsplash
- NSE filed its DRHP with SEBI on June 17, 2026, targeting a ₹30,000 crore (~$3.17 billion) IPO — the largest public offering in Indian market history, surpassing Hyundai Motor India's ₹27,859 crore from October 2024.
- The offering is entirely an Offer for Sale (OFS) of 148.9 million shares (~6% of paid-up capital); no fresh capital enters NSE — proceeds flow to selling shareholders including SBI, Canada Pension Plan, and Temasek.
- FY26 net profit fell to ₹10,302 crore, down 15% from ₹12,188 crore in FY25, driven by SEBI's tighter derivatives regulations — with F&O options contributing ~60% of NSE's total operating revenue.
- At an estimated ₹1,600–1,800 per share, NSE would price at 38–43x FY26 P/E, versus BSE's current 69x FY26 multiple — a discount that is complicated by the fact that NSE's earnings declined while BSE's grew.
The Thesis — One Falsifiable Claim
Ten years. That is how long India's largest stock exchange spent in regulatory limbo, unable to list itself following a server-access scandal that shook institutional trust in 2015. On June 17, 2026, the National Stock Exchange of India filed its Draft Red Herring Prospectus (DRHP) with SEBI, launching what could become the country's largest-ever public offering at ₹30,000 crore (~$3.17 billion). According to reporting aggregated by Google News, the decade-long delay ended with a settlement exceeding ₹1,388 crore and a formal SEBI no-objection certificate issued on January 30, 2026 — clearing the runway for the June filing.
Thesis: NSE's IPO is worth researching as a structural play on India's capital market deepening — but investors are paying 38–43x P/E for a business whose primary revenue engine was clipped by the same regulator that cleared it to list. FY27 net profit recovery above ₹11,500 crore is the single data point that validates or breaks this thesis.
The transaction covers an Offer for Sale of 148.9 million equity shares representing approximately 6% of NSE's paid-up capital. Sellers include State Bank of India (2.48 crore shares), Canada Pension Plan Investment Board, and Singapore's Temasek Holdings. A record 20 merchant bankers were appointed — the highest ever for an Indian public issue — signaling both the deal's scale and its structural complexity.
What's on the Table — NSE's Market Position
The structural bull case starts with a form of market dominance that is genuinely rare among listed exchange operators anywhere in the world. As of May 2026, NSE lists 1,716 companies with a combined market capitalization of $3.57 trillion, placing it as the 5th largest stock exchange globally. The exchange commands 93% of India's cash equity market and effectively 100% of equity futures trading — a near-monopoly position with no credible near-term challenger.
In the unlisted private market, NSE's valuation stands at ₹5 lakh crore (~$57 billion), which would rank it alongside Nasdaq, Hong Kong Exchanges, and Deutsche Börse as the 5th most valuable exchange in the world. Ravi Varanasi, former NSE Group President, frames the long-term opportunity directly: "As India's market capitalisation deepens, cash trading volumes are expected to rise steadily." With 220 IPOs processed year-to-date through May 2026 — including 12 fintech and enterprise tech listings — that structural tailwind has observable, data-backed momentum. Investors tracking India's capital market trends are watching this listing as a benchmark event for the country's next phase of financial market development.
India's most valuable companies as of April 2026 illustrate the broader market NSE sits atop: Reliance Industries leads at $200B+ market cap, followed by HDFC Bank, Bharti Airtel, State Bank of India, and ICICI Bank — four of the top ten being financial services firms. NSE at ~$57 billion at listing would enter the upper tier of that hierarchy on day one. The timing also coincides with Reliance Jio Platforms, expected to file its own DRHP with SEBI the same week, potentially creating back-to-back record-breaking IPOs in Indian capital market history.
Photo by Punit Chawla on Unsplash
The Evidence — Where the Valuation Math Gets Complicated
NSE's FY26 financials reveal a business of exceptional quality facing a structural revenue challenge. Revenue for the year came in at ₹16,601 crore with net profit of ₹10,302 crore, generating a profit margin of 62.9% — meaningfully above BSE's 52.3%. On quality metrics alone, the competitive position is clear.
But direction matters as much as level in stock analysis. FY25 net profit was ₹12,188 crore. The FY26 figure represents a 15% year-over-year decline, driven directly by SEBI's tighter derivatives trading regulations. Transaction charges represent 78.65% of NSE's total revenue, and F&O options contracts contribute approximately 60% of total operating revenue. When regulators adjust derivatives market parameters, NSE's income statement absorbs the impact almost immediately.
Chart: NSE vs BSE — profit margins (left) and implied FY26 P/E multiples (right). NSE's margin advantage is real; its P/E discount relative to BSE is complicated by the earnings decline trajectory. Data as of June 18, 2026.
Analysts at Multibagg.ai captured the investment research community's core concern: "FY26 was actually down from FY25 on both revenue and profit, which is significant because SEBI F&O curbs broke the 'exchanges only go up' narrative." That narrative — that exchange operators passively compound market growth with minimal incremental cost — is exactly what BSE's 69x FY26 P/E reflects. NSE at 38–43x appears to be a discount, but it is a discount on a declining earnings base, not a growing one. Those are fundamentally different propositions.
Market analysts quoted by MarketScreener have indicated that "NSE may offer shares at a 5% to 10% discount to private market valuations, with the valuation under discussion at around 1,900 rupees per share." At that level, the entry premium for retail investors remains substantial relative to demonstrated FY26 earnings power.
Readers researching how passive investment flows interact with exchange infrastructure may find useful grounding in the sector analysis at finance.newslens.me's Index Funds vs. ETFs breakdown — the index-linked products traded across NSE's platform are a direct driver of the transaction charges that represent 78.65% of its total revenue.
The Bear Case Deserves Better Than a Paragraph
The standard NSE bear case gets labeled "regulatory risk" and quickly moved on from. It deserves more precise dissection — there are three distinct vectors at play.
Revenue concentration. F&O options generating approximately 60% of operating revenue means NSE's earnings are structurally exposed to a single product category that regulators have already targeted — and already moved against. The FY26 profit decline is not a hypothetical tail risk. It has already materialized. A second round of derivatives restrictions in FY27 or beyond would pressure a valuation case that was built on the assumption of earnings recovery, not further compression.
The OFS structure sends an institutional signal. This IPO raises zero capital for NSE itself. SBI, Canada Pension Plan, and Temasek — institutions with full access to NSE's internal financial disclosures, legal exposure documentation, and multi-year holding-period flexibility — are positioned as sellers in this transaction. That is not automatically bearish (large holders exit for portfolio and mandate reasons), but it is a fact worth naming clearly: public market buyers are on the other side of decisions made by well-informed institutional capital.
Regulatory dependency runs in both directions. NSE's market position is protected by enormous regulatory barriers to competition — a genuine, durable moat. But the same SEBI authority that cleared NSE to list can reshape its revenue model at any annual policy review. The co-location controversy, the ₹1,388+ crore settlement, and the decade-long IPO delay are evidence that this relationship can be adversarial. Any investment research framework for this listing should price regulatory optionality explicitly, not treat it as background noise.
When I review the full picture here, I'd argue the bear case is not a footnote — it is a central variable in any serious position-sizing analysis. The business quality is exceptional; the entry conditions are genuinely complicated.
Watchlist — Metrics and Dates to Track
As of June 18, 2026, these are the specific data points investors are watching for NSE's post-listing trajectory:
- Q1 FY27 Earnings (expected August 2026): The first post-listing profit read. Recovery toward ₹11,500+ crore would support the re-acceleration thesis. Further compression would expose the 38–43x P/E as structurally unjustifiable and likely trigger a re-rating downward.
- Final IPO Price Band: Not formally set as of June 18, 2026. Private market discussions have centered on ₹1,900/share; official disclosure follows SEBI review. The difference between ₹1,600 and ₹1,800 per share implies meaningfully different entry valuations, and the range matters for institutional demand signals at the subscription stage.
- SEBI Derivatives Policy Calendar: Any further adjustments to F&O lot sizes, margin requirements, or contract expiry structures will move NSE's forward earnings estimates directly. This is the highest-impact single external variable on the entire investment thesis.
- Reliance Jio DRHP Timing: Expected to be filed the same week as NSE, per current market reporting. Two mega-IPOs competing simultaneously for institutional capital allocation is a practical demand consideration for NSE's subscription dynamics — not a dealbreaker, but a variable.
- BSE P/E Convergence: BSE trades at 69x FY26 and 50x FY27E P/E. If NSE lists at 38–43x with stabilizing or recovering FY27 earnings, the re-rating potential is real. If FY27 earnings remain flat, the gap reflects a fundamentals difference, not a mispricing opportunity.
Frequently Asked Questions
What is the NSE IPO issue size, and how does the price band affect implied valuation?
As of June 18, 2026, NSE's DRHP targets a ₹30,000 crore (~$3.17 billion) IPO through an OFS of 148.9 million shares representing approximately 6% of paid-up capital. The final price band has not been officially announced, but market discussions have centered on ₹1,600–1,800 per share, with private market valuation discussions around ₹1,900. At those levels, the implied P/E ratio (stock price divided by annual earnings per share) ranges from 38–43x based on FY26 net profit of ₹10,302 crore. Higher pricing compresses the discount-to-BSE argument and increases the burden on FY27 earnings recovery.
Why was the NSE IPO delayed for nearly 10 years, and what changed in 2026?
NSE's listing was stalled following a 2015 co-location controversy in which certain high-frequency trading (HFT) firms allegedly received preferential server access at NSE data centers, enabling faster order execution than other market participants. NSE settled the case for more than ₹1,388 crore and received a formal SEBI no-objection certificate on January 30, 2026, clearing the regulatory path for the June 17, 2026 DRHP filing. The decade-long gap means NSE approaches its IPO with a profit trajectory that has already peaked — at least in the near term.
How does NSE's IPO P/E compare to BSE's current valuation multiple?
At the estimated IPO price of ₹1,600–1,800 per share, NSE would price at 38–43x FY26 P/E (price-to-earnings, or the stock price divided by annual earnings per share). BSE currently trades at 69x FY26 P/E and 50x FY27E P/E. The discount appears significant on the surface, but the comparison is complicated by earnings direction: BSE's premium reflects growing profits, while NSE's FY26 net profit declined 15% year-over-year from ₹12,188 crore to ₹10,302 crore. Investors tracking both stocks are watching Q1 FY27 results as the first signal on whether NSE's trajectory reversal justifies the narrowing valuation gap.
Is NSE IPO worth researching as an investment given the FY26 profit decline?
Research data positions NSE as worth researching for long-horizon investors focused on India's capital market deepening. Its 93% cash equity market share, near-total equity futures dominance, and 62.9% profit margin reflect a durable competitive moat. However, the 15% FY26 profit decline driven by SEBI's F&O regulations is a structural concern, not one-time noise — F&O options represent ~60% of operating revenue, and the regulatory ceiling on that category has already been demonstrated. Investors considering this listing should monitor Q1 FY27 earnings (expected August 2026) as the first post-listing signal on whether the recovery thesis is intact. This is educational analysis only, not financial advice.
Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions. Research based on publicly available sources current as of June 18, 2026.